Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients

Respiratory Medicine

Volumn 123, Issue , 2017, Pages 56-62

  Ahmad, Kais ^a   Barba, Thomas ^a   Gamondes, Delphine ^b   Ginoux, Marylise ^a   Khouatra, Chahera ^a   Spagnolo, Paolo ^c   Strek, Mary ^d   Thivolet Béjui, Françoise ^a   Traclet, Julie ^a   Cottin, Vincent ^a  

^a UNIVERSITÉ LYON 1   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Connected tissue disease; Idiopathic pulmonary fibrosis; Interstitial lung disease; Interstitial pneumonia

Indexed keywords

ANTIFIBROTIC AGENT; ANTINUCLEAR ANTIBODY; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DNA TOPOISOMERASE ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LA ANTIBODY; RO ANTIBODY; SM ANTIBODY; SYNTHETASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; CAPILLAROSCOPY; CHRONIC RESPIRATORY FAILURE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DYSPNEA; FEMALE; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG LAVAGE; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MYALGIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMYOSITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; X-RAY COMPUTED TOMOGRAPHY; XEROPHTHALMIA; XEROSTOMIA; AGED; ANGIOSCOPY; DIFFERENTIAL DIAGNOSIS; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

AGED; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; LUNG DISEASES, INTERSTITIAL; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85006867250     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2016.10.017     Document Type: Article

References (32)

1. [1] Fischer, A., du Bois, R., Interstitial lung disease in connective tissue disorders. Lancet 380 (2012), 689–698.
2. [2] Kinder, B.W., Collard, H.R., Koth, L., Daikh, D.I., Wolters, P.J., Elicker, B., Jones, K.D., King, T.E. Jr., Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?. Am. J. Respir. Crit. Care Med. 176 (2007), 691–697.
3. [3] Corte, T.J., Copley, S.J., Desai, S.R., Zappala, C.J., Hansell, D.M., Nicholson, A.G., Colby, T.V., Renzoni, E., Maher, T.M., Wells, A.U., Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur. Respir. J. 39 (2012), 661–668.
4. [4] Song, J.W., Do, K.-H., Kim, M.-Y., Jang, S.J., Colby, T.V., Kim, D.S., Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 136 (2009), 23–30.
5. [5] Devouassoux, G., Cottin, V., Liote, H., Marchand, E., Frachon, I., Schuller, A., Bejui-Thivolet, F., Cordier, J.F., Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur. Respir. J. 33 (2009), 1053–1061.
6. [6] Fischer, A., West, S.G., Swigris, J.J., Brown, K.K., du Bois, R.M., Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 138 (2010), 251–256.
7. [7] Park, J.H., Kim, D.S., Park, I.N., Jang, S.J., Kitaichi, M., Nicholson, A.G., Colby, T.V., Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med. 175 (2007), 705–711.
8. [8] Navaratnam, V., Ali, N., Smith, C.J., McKeever, T., Fogarty, A., Hubbard, R.B., Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis?. Respir. Med. 105 (2011), 1925–1930.
9. [9] Fischer, A., Brown, K.K., Du Bois, R.M., Frankel, S.K., Cosgrove, G.P., Fernandez-Perez, E.R., Huie, T.J., Krishnamoorthy, M., Meehan, R.T., Olson, A.L., Solomon, J.J., Swigris, J.J., Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J. Rheumatol. 40 (2013), 640–646.
10. [10] Tashkin, D.P., Elashoff, R., Clements, P.J., Goldin, J., Roth, M.D., Furst, D.E., Arriola, E., Silver, R., Strange, C., Bolster, M., Seibold, J.R., Riley, D.J., Hsu, V.M., Varga, J., Schraufnagel, D.E., Theodore, A., Simms, R., Wise, R., Wigley, F., White, B., Steen, V., Read, C., Mayes, M., Parsley, E., Mubarak, K., Connolly, M.K., Golden, J., Olman, M., Fessler, B., Rothfield, N., Metersky, M., Cyclophosphamide versus placebo in scleroderma lung disease. N. Engl. J. Med. 354 (2006), 2655–2666.
11. [11] Vij, R., Noth, I., Strek, M.E., Autoimmune-featured interstitial lung disease: A distinct entity. Chest 140 (2011), 1292–1299.
12. [12] Fischer, A., Antoniou, K.M., Brown, K.K., Cadranel, J., Corte, T.J., du Bois, R.M., Lee, J.S., Leslie, K.O., Lynch, D.A., Matteson, E.L., Mosca, M., Noth, I., Richeldi, L., Strek, M.E., Swigris, J.J., Wells, A.U., West, S.G., Collard, H.R., Cottin, V., An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur. Respir. J. 46 (2015), 976–987.
13. [13] Raghu, G., Collard, H.R., Egan, J.J., Martinez, F.J., Behr, J., Brown, K.K., Colby, T.V., Cordier, J.F., Flaherty, K.R., Lasky, J.A., Lynch, D.A., Ryu, J.H., Swigris, J.J., Wells, A.U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D.M., Johkoh, T., Kim, D.S., King, T.E. Jr., Kondoh, Y., Myers, J., Muller, N.L., Nicholson, A.G., Richeldi, L., Selman, M., Dudden, R.F., Griss, B.S., Protzko, S.L., Schunemann, H.J., An Official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183 (2011), 788–824.
14. [14] Galie, N., Humbert, M., Vachiery, J.L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., Ghofrani, A., Gomez Sanchez, M.A., Hansmann, G., Klepetko, W., Lancellotti, P., Matucci, M., McDonagh, T., Pierard, L.A., Trindade, P.T., Zompatori, M., Hoeper, M., ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Respir. J. 46 (2015), 903–975 2015.
15. [15] Mosca, M., Tani, C., Bombardieri, S., A case of undifferentiated connective tissue disease: is it a distinct clinical entity?. Nat. Clin. Pract. Rheumatol. 4 (2008), 328–332.
16. [16] Oldham, J.M., Adegunsoye, A., Valenzi, E., Lee, C., Witt, L., Chen, L., Husain, A.N., Montner, S., Chung, J.H., Cottin, V., Fischer, A., Noth, I., Vij, R., Strek, M.E., Characterisation of patients with interstitial pneumonia with autoimmune features. Eur. Respir. J. 47 (2016), 1767–1775.
17. [17] van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S.R., Baron, M., Tyndall, A., Matucci-Cerinic, M., Naden, R.P., Medsger, T.A. Jr., Carreira, P.E., Riemekasten, G., Clements, P.J., Denton, C.P., Distler, O., Allanore, Y., Furst, D.E., Gabrielli, A., Mayes, M.D., van Laar, J.M., Seibold, J.R., Czirjak, L., Steen, V.D., Inanc, M., Kowal-Bielecka, O., Muller-Ladner, U., Valentini, G., Veale, D.J., Vonk, M.C., Walker, U.A., Chung, L., Collier, D.H., Ellen Csuka, M., Fessler, B.J., Guiducci, S., Herrick, A., Hsu, V.M., Jimenez, S., Kahaleh, B., Merkel, P.A., Sierakowski, S., Silver, R.M., Simms, R.W., Varga, J., Pope, J.E., Classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann. Rheum. Dis. 72 (2013), 1747–1755 2013.
18. [18] Kim, H.C., Ji, W., Kim, M.Y., Colby, T.V., Jang, S.J., Lee, C.K., Han, S.B., Kim, D.S., Interstitial pneumonia related to undifferentiated connective tissue disease: pathologic pattern and prognosis. Chest 147 (2015), 165–172.
19. [19] Fischer, A., Meehan, R.T., Feghali-Bostwick, C.A., West, S.G., Brown, K.K., Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest 130 (2006), 976–981.
20. [20] Cutolo, M., Smith, V., State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?. Rheumatol. Oxf. 52 (2013), 1933–1940.
21. [21] Fischer, A., Swigris, J.J., du Bois, R.M., Groshong, S.D., Cool, C.D., Sahin, H., Lynch, D.A., Gillis, J.Z., Cohen, M.D., Meehan, R.T., Brown, K.K., Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest 136 (2009), 1072–1078.
22. [22] Strand, M.J., Sprunger, D., Cosgrove, G.P., Fernandez-Perez, E.R., Frankel, S.K., Huie, T.J., Olson, A.L., Solomon, J., Brown, K.K., Swigris, J.J., Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia. Chest 146 (2014), 775–785.
23. [23] Omote, N., Taniguchi, H., Kondoh, Y., Watanabe, N., Sakamoto, K., Kimura, T., Kataoka, K., Johkoh, T., Fujimoto, K., Fukuoka, J., Otani, K., Nishiyama, O., Hasegawa, Y., Lung-dominant connective tissue disease: clinical, radiologic, and histologic features. Chest 148 (2015), 1438–1446.
24. [24] Kim, E.J., Elicker, B.M., Maldonado, F., Webb, W.R., Ryu, J.H., Van Uden, J.H., Lee, J.S., King, T.E. Jr., Collard, H.R., Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur. Respir. J. 35 (2010), 1322–1328.
25. [25] Fischer, A., Collard, H.R., Cottin, V., Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened. Eur. Respir. J. 47 (2016), 1295–1296.
26. [26] Cottin, V., Nunes, H., Mouthon, L., Gamondes, D., Lazor, R., Hachulla, E., Revel, D., Valeyre, D., Cordier, J.F., Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum. 63 (2011), 295–304.
27. [27] Antoniou, K.M., Margaritopoulos, G.A., Goh, N.S., Karagiannis, K., Desai, S.R., Nicholson, A.G., Siafakas, N.M., Coghlan, J.G., Denton, C.P., Hansell, D.M., Wells, A.U., Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension. Arthritis Rheumatol. 68 (2016), 1004–1012.
28. [28] Cottin, V., Thivolet-Bejui, F., Reynaud-Gaubert, M., Cadranel, J., Delaval, P., Ternamian, P.J., Cordier, J.F., Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur. Respir. J. 22 (2003), 245–250.
29. [29] Tansey, D., Wells, A.U., Colby, T.V., Ip, S., Nikolakoupolou, A., du Bois, R.M., Hansell, D.M., Nicholson, A.G., Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 44 (2004), 585–596.
30. [30] Bouros, D., Wells, A.U., Nicholson, A.G., Colby, T.V., Polychronopoulos, V., Pantelidis, P., Haslam, P.L., Vassilakis, D.A., Black, C.M., Du Bois, R.M., Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med. 165 (2002), 1581–1586.
31. [31] Douglas, W.W., Tazelaar, H.D., Hartman, T.E., Hartman, R.P., Decker, P.A., Schroeder, D.R., Ryu, J.H., Polymyositis-dermatomyositis-associated interstitial lung disease. Am. J. Respir. Crit. Care Med. 164 (2001), 1182–1185.
32. [32] Rajasekaran, A., Shovlin, D., Saravanan, V., Lord, P., Kelly, C., Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years. J. Rheumatol. 33 (2006), 1250–1253.